BGT – Bio-Gene Technology
Beta-triketone compounds have demonstrated insecticidal activity (eg kill or knock down insects) via a novel mode of action in testing performed to date. This platform may provide multiple potential new solutions for insecticide manufacturers in applications across animal health and crop protection, as well as in public health, and in consumer applications.
The Company’s aim is to develop and commercialise a broad portfolio of targeted insect control management solutions.
It is anticipated that BGT will list on the ASX during November 2017.